Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2020 Results - Earnings Call Transcript
Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Qualigen Therapeutics, Inc. (QLGN) CEO Michael Poirier on Q1 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Y-mAbs Therapeutics, Inc. (YMAB) CEO Claus Moller on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Ra Medical Systems, Inc. (RMED) CEO Jonathan McGuire on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Lyra Therapeutics, Inc. (LYRA) CEO Maria Palasis on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha